| RNXT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the RNXT shares outstanding history going back to 11/1/2021:
Also see: RNXT Market Cap History RNXT YTD Return |
As of 5/7/2026 RenovoRx has 45.10 million RNXT shares outstanding. Investors often track the RNXT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RNXT share count trends over time, with 19 historical shares outstanding datapoints presented, dating back to 11/1/2021.

| RNXT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the RNXT shares outstanding history going back to 11/1/2021:
Also see: RNXT Market Cap History RNXT YTD Return |
| RNXT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||
RNXT Historical Shares Outstanding: +43.22% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||
| RNXT Stock Price Chart |
| About RenovoRx Inc |
| RenovoRx, Inc. is a clinical-stage biopharmaceutical company. Co. is developing targeted combination therapies for high unmet medical needs with a goal of improving therapeutic outcomes for cancer patients undergoing treatment. Its Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy. Its portfolio of cancer therapies is based on its lead product candidate, RenovoGem (gemcitabine delivered via its delivery system). Its phase III lead product candidate, RenovoGem, is a novel oncology drug-device combination product. We show 19 historical shares outstanding datapoints in our coverage of RNXT's shares outstanding history. Understanding the changing numbers of RNXT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RNXT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RNXT by allowing them to research RNXT shares outstanding history as well as any other stock in our coverage universe. |
| RNXT Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| RNXT Share Performance |
| Shares Outstanding Peers |
| RenovoRx (RNXT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RPHM Shares Outstanding History RPID Shares Outstanding History RPRX Shares Outstanding History RSLS Shares Outstanding History RTIX Shares Outstanding History RTRX Shares Outstanding History RTTR Shares Outstanding History RUBY Shares Outstanding History RVMD Shares Outstanding History RVNC Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.